Jinghua Pharmaceutical Group Bilan de santé
Santé financière contrôle des critères 6/6
Jinghua Pharmaceutical Group has a total shareholder equity of CN¥2.9B and total debt of CN¥25.9M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are CN¥3.2B and CN¥319.6M respectively. Jinghua Pharmaceutical Group's EBIT is CN¥261.8M making its interest coverage ratio -7.1. It has cash and short-term investments of CN¥1.2B.
Informations clés
0.9%
Ratio d'endettement
CN¥25.92m
Dette
| Ratio de couverture des intérêts | -7.1x |
| Argent liquide | CN¥1.23b |
| Fonds propres | CN¥2.87b |
| Total du passif | CN¥319.61m |
| Total des actifs | CN¥3.19b |
Mises à jour récentes de la santé financière
Recent updates
Analyse de la situation financière
Passif à court terme: 002349's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥301.7M).
Passif à long terme: 002349's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥17.9M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 002349 has more cash than its total debt.
Réduire la dette: 002349's debt to equity ratio has reduced from 20.7% to 0.9% over the past 5 years.
Couverture de la dette: 002349's debt is well covered by operating cash flow (1112.7%).
Couverture des intérêts: 002349 earns more interest than it pays, so coverage of interest payments is not a concern.